Breaking News Instant updates and real-time market news.

ADSK

Autodesk

$75.18

-0.65 (-0.86%)

, SPLK

Splunk

$57.42

-0.91 (-1.56%)

14:31
11/29/16
11/29
14:31
11/29/16
14:31

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Autodesk (ADSK), consensus (24c)... Splunk (SPLK), consensus 8c... Guidewire Software (GWRE), consensus 5c.

ADSK

Autodesk

$75.18

-0.65 (-0.86%)

SPLK

Splunk

$57.42

-0.91 (-1.56%)

GWRE

Guidewire

$58.16

-0.21 (-0.36%)

  • 29

    Nov

  • 29

    Nov

  • 29

    Nov

  • 06

    Dec

ADSK Autodesk
$75.18

-0.65 (-0.86%)

09/14/16
EVER
09/14/16
INITIATION
Target $80
EVER
Buy
Autodesk initiated with a Buy at Evercore ISI
Target $80.
11/21/16
BARD
11/21/16
NO CHANGE
Target $85
BARD
Outperform
Autodesk price target raised to $85 from $75 at Baird
Baird analyst Steven Ashley raised his price target on Autodesk to $85 from $75 following mixed channel check results that were consistent with guidance. The analyst remains bullish on the shares as he believes there will be a steady stream of positive forward-looking metrics beginning next quarter, including subscriber growth, ARR, and deferred revenue. Ashley reiterated his Outperform rating on Autodesk shares.
11/22/16
WEDB
11/22/16
NO CHANGE
WEDB
Autodesk checks mixed, says Wedbush
After conducting checks with resellers, Wedbush analyst Steve Koenig thinks that Autodesk's net subscriber additions were "strong" in Q3, while its revenue outlook for 2H16 "looks middling." The analyst adds that the company's Q3 revenue appears to have been "mostly in-line with muted...expectations," while there were "isolated reports" of November beginning weaker than expected. He raised his price target on the shares to $70 from $60 and reiterates a Neutral rating.
08/30/16
08/30/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Autodesk (ADSK) downgraded to Sell from Neutral at Rosenblatt, as analyst Kirk Adams believes the shares are "priced for perfection" through fiscal year 2020. 2. Pacific Crest analyst Rob Owens downgraded Imperva (IMPV) to Sector Weight from Overweight, saying the company's fundamentals continue to be challenged. The analyst sees a "limited number" of strategic suitors for Imperva and thinks the current share price could prevent "meaningful upside" should a buyer step in. Owens coupled the downgrade with upgrades this morning of Barracuda (CUDA) and Fortinet (FTNT) to Overweight. 3. ManTech (MANT) downgraded to Underperform from Market Perform at Wells Fargo, with analyst Ed Caso citing valuation. Caso believes the shares are "ahead of themselves" and he keeps a $33-$34 price target range for the name. 4. Signet Jewelers (SIG) downgraded to Neutral from Overweight at JPMorgan by analyst Anne Samuel, citing fundamental headwinds after the company lowered its 2017 outlook. 5. Seaport Global analysts led by Mike Kelly downgraded Rice Energy (RICE) and Marathon Oil (MRO), each to Neutral from Buy, citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SPLK Splunk
$57.42

-0.91 (-1.56%)

11/28/16
WBLR
11/28/16
NO CHANGE
WBLR
Outperform
Splunk risk/reward favorable into earnings, says William Blair
William Blair analyst Bhavan Suri says almost every Splunk partner his firm spoke with indicated that business was at least in line with expectations during the quarter. His work suggests $3M-$6M outperformance on total revenue for Splunk's Q3, which could translate to modest upside on operating income and earnings. The analyst views the stock's risk/reward as favorable into tomorrow's results. Suri keeps an Outperform rating on Splunk.
11/28/16
JMPS
11/28/16
NO CHANGE
JMPS
Splunk made major deal with State Department, says JMP Securities
JMP Securities analyst Greg McDowell reports that Splunk made "a multiyear federal deal with the State Department" worth a total of $25M. The analyst says that the contract could be "the largest federal deal in Splunk's history." He keeps a $70 price target and an Outperform rating on the shares.
10/14/16
PIPR
10/14/16
INITIATION
Target $70
PIPR
Overweight
Splunk assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Alex Zukin assumed coverage of Splunk with an Overweight rating and $70 price target. The analyst views the company as a "category-defining market leader that essentially throws a paddle to companies swimming in a sea of data." He sees few direct competitors and a $45B total addressable market.
10/04/16
GUGG
10/04/16
DOWNGRADE
GUGG
Neutral
Splunk downgraded to Neutral from Buy at Guggenheim
GWRE Guidewire
$58.16

-0.21 (-0.36%)

10/04/16
GSCO
10/04/16
INITIATION
Target $57
GSCO
Neutral
Guidewire initiated with a Neutral at Goldman
Goldman analyst Jesse Hulsing initiated Guidewire with a Neutral and a $57 price target saying shares are fairly valued.
09/16/16
09/16/16
DOWNGRADE
Target $60

Underperform
Guidewire downgraded to Underperform on valuation at BofA/Merrill
As previously reported, BofA downgraded Guidewire to Underperform from Neutral and lowered its price target to $60 from $64. Analyst Brad Sills said Guidewire are trading at a premium to peers and shares are fully valued.
09/16/16
BOFA
09/16/16
DOWNGRADE
BOFA
Underperform
Guidewire downgraded to Underperform from Neutral at BofA/Merrill
09/08/16
UBSW
09/08/16
NO CHANGE
Target $70
UBSW
Buy
Guidewire weakness a buying opportunity, says UBS
UBS analyst Brent Thill noted Guidewire investors may be concerned about its 2017 guidance, but he believes it is conservative from a historical perspective. The analyst feels any weakness in Guidewire shares would be a buying opportunity, citing its zero churn rate, stable P&C insurance end market, increasing customer referencing, and the long commitments that P&C insurers make to the company. Thill reiterated his Buy rating and $70 price target on Guidewire shares.

TODAY'S FREE FLY STORIES

MRTX

Mirati Therapeutics

$10.80

-0.4 (-3.57%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Initiation
Mirati Therapeutics initiated  »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Post Holdings, Bob Evans »

Post Holdings to acquire…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$76.50

3.7 (5.08%)

, SSNI

Silver Spring

$16.10

3.1 (23.85%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Downgrade
Itron, Silver Spring rating change  »

Itron downgraded to Hold…

ITRI

Itron

$76.50

3.7 (5.08%)

SSNI

Silver Spring

$16.10

3.1 (23.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Bob Evans »

Bob Evans trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.42

0.32 (0.86%)

, CRM

Salesforce

$95.74

1.11 (1.17%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

T

AT&T

$37.42

0.32 (0.86%)

CRM

Salesforce

$95.74

1.11 (1.17%)

AXON

Axovant Sciences

$22.88

1.54 (7.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Nov

Q

QuintilesIMS

$95.07

0.6 (0.64%)

07:29
09/19/17
09/19
07:29
09/19/17
07:29
Initiation
QuintilesIMS initiated  »

QuintilesIMS initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$24.35

1.77 (7.84%)

07:27
09/19/17
09/19
07:27
09/19/17
07:27
Recommendations
Meritor analyst commentary  »

Meritor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$17.37

-0.42 (-2.36%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Technical Analysis
Technical View: Under Armour falls, analyst action »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

CAH

Cardinal Health

$67.07

-0.43 (-0.64%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Initiation
Cardinal Health initiated  »

Cardinal Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

HAS

Hasbro

$93.24

-1.6 (-1.69%)

, MAT

Mattel

$14.87

-0.99 (-6.24%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Hot Stocks
Toys"R"Us confirms filing Chapter 11 bankruptcy petitions in U.S. »

Toys"R"Us…

HAS

Hasbro

$93.24

-1.6 (-1.69%)

MAT

Mattel

$14.87

-0.99 (-6.24%)

JAKK

JAKKS Pacific

$2.85

-0.2 (-6.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

, FB

Facebook

$170.01

-1.63 (-0.95%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Recommendations
Amazon.com, Facebook, Alphabet, Alphabet Class A, Activision Blizzard, Electronic Arts, Take-Two analyst commentary  »

KeyBanc remains positive…

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

FB

Facebook

$170.01

-1.63 (-0.95%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

ATVI

Activision Blizzard

$64.20

-0.8 (-1.23%)

EA

Electronic Arts

$119.96

0.54 (0.45%)

TTWO

Take-Two

$100.82

0.43 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

ACDVF

Air Canada

$19.26

-0.7713 (-3.85%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Conference/Events
Air Canada to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

XLRN

Acceleron

$39.38

-0.53 (-1.33%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Conference/Events
Acceleron to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

BIG

Big Lots

$49.05

-0.97 (-1.94%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Conference/Events
Big Lots to host analyst and investor meeting »

Analyst and Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 27

    Sep

CALD

Callidus Software

$26.05

0.55 (2.16%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Conference/Events
Callidus Software to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

ONB

Old National Bancorp

$16.70

0.3 (1.83%)

07:24
09/19/17
09/19
07:24
09/19/17
07:24
Upgrade
Old National Bancorp rating change  »

Old National Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABC

AmerisourceBergen

$80.67

-0.93 (-1.14%)

07:24
09/19/17
09/19
07:24
09/19/17
07:24
Initiation
AmerisourceBergen initiated  »

AmerisourceBergen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

MDGS

Medigus

$2.03

0.08 (4.10%)

07:22
09/19/17
09/19
07:22
09/19/17
07:22
Technical Analysis
Technical View: Medigus moves up sharply in early trading »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$82.60

0.1 (0.12%)

07:21
09/19/17
09/19
07:21
09/19/17
07:21
Initiation
Walgreens Boots Alliance initiated  »

Walgreens Boots Alliance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

CMG

Chipotle

$301.87

-11.22 (-3.58%)

07:21
09/19/17
09/19
07:21
09/19/17
07:21
Periodicals
Customers criticize Chipotle's 'queso' dip on social media, Reuters reports »

Shares of Chipotle are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTO

ZTO Express

$14.89

-0.18 (-1.19%)

07:20
09/19/17
09/19
07:20
09/19/17
07:20
Initiation
ZTO Express initiated  »

ZTO Express initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$16.75

0.64 (3.97%)

07:20
09/19/17
09/19
07:20
09/19/17
07:20
Hot Stocks
Synchronoss drops 12% after Siris withdraws acquisition interest »

Siris Capital Group on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$16.75

0.64 (3.97%)

07:19
09/19/17
09/19
07:19
09/19/17
07:19
Technical Analysis
Technical View: Synchronoss falls sharply after Siris drops all-cash offer »

The stock was last at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$83.31

0.14 (0.17%)

07:18
09/19/17
09/19
07:18
09/19/17
07:18
Initiation
CVS Health initiated  »

CVS Health initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 17

    Oct

MZOR

Mazor Robotics

$46.99

2.29 (5.12%)

07:16
09/19/17
09/19
07:16
09/19/17
07:16
Hot Stocks
Migdal takes 4.92% passive stake in Mazor Robotics »

Migdal Insurance &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.